B
신일제약
012790KOSDAQ의약품 제조업59.5 / 100
Reference Date: 2026-04-13
Financial Score28.0 / 40
News Sentiment12.5 / 25
Momentum9.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Roughly flat over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
Shinil Pharmaceutical, established in 1971, specializes in the production and sale of various pharmaceuticals such as tablets, capsules, and ointments, while also operating a CDMO business. The company diversifies its operations through the 'Pamtree' brand, offering functional cosmetics and health supplements, alongside revenue from medical devices and real estate rentals.
Number of Employees
413people
Average Salary
49.9M KRW
Score Calculation Basis
Detailed Financial Score
PER
9.28Industry Average 14.806.5Point
Lower than industry avg (good)
PBR
0.48Industry Average 1.047.0Point
Half of industry avg (excellent)
ROE
5.04Industry Average 4.424.0Point
In line with industry avg
Debt Ratio
1.62Industry Average 11.988.0Point
Half of industry avg (excellent)
Trend 2023~20252.5 / 10 points
Revenue Growth Rate
0.5 / 3
Avg ▼4.8% (2-year basis)
Operating Profit Growth Rate
0.0 / 3
Avg ▼21.3% (2-year basis)
ROE Trend
2.0 / 4
Avg ROE 8.6% (declining, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position3.0Point
52w lower range (29%)
Current 6,040Won52-week high 6,92052-week low 5,680
1-month return3.0Point
1m -0.82% (flat)
Volume trend3.0Point
Volume flat
Detailed Disclosure
4 totalPositive 0Neutral 4Negative 0
- Neutral정기주주총회결과2026-03-26
- Neutral[기재정정]정기주주총회결과2026-03-26
- Neutral사업보고서 (2025.12)2026-03-18
- Neutral감사보고서제출2026-03-17